These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2193315)

  • 1. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
    Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma homovanillic acid in schizophrenics: supportive evidence for the two-subtype hypothesis.
    Chen TY; Lee CF; Lung FW; Lee TC; Lin WL; Hu WH; Yeh EK; Chang WH
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):584-8. PubMed ID: 2571672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.
    Arrúe A; Dávila R; Zumárraga M; Basterreche N; González-Torres MA; Goienetxea B; Zamalloa MI; Anguiano JB; Guimón J
    Neurochem Res; 2010 Feb; 35(2):247-53. PubMed ID: 19701707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increments in plasma homovanillic acid concentrations after neuroleptic discontinuation are associated with worsening of schizophrenic symptoms.
    Khan RS; Amin F; Powchik P; Knott P; Goldstein M; Apter S; Kerman B; Jaff S; Davidson M
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):879-84. PubMed ID: 1980541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
    Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
    Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ; Reynolds GP; Ramchand C; Peet M; Shah S
    Acta Pharmacol Sin; 2001 Jan; 22(1):76-80. PubMed ID: 11730567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T; Saitoh O; Yotsutsuji T; Itoh H; Kurokawa K; Kurachi M
    Neuropsychopharmacology; 1999 Apr; 20(4):365-9. PubMed ID: 10088137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: relation to neuroleptic resistance.
    Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
    Biol Psychiatry; 1997 Mar; 41(5):560-6. PubMed ID: 9046988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response.
    Koreen AR; Lieberman J; Alvir J; Mayerhoff D; Loebel A; Chakos M; Amin F; Cooper T
    Arch Gen Psychiatry; 1994 Feb; 51(2):132-8. PubMed ID: 7905259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R; Zumárraga M; Basterreche N; Arrúe A; Anguiano JB
    Psychiatry Res; 2007 May; 151(1-2):163-8. PubMed ID: 17434602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homovanillic acid in untreated schizophrenia--relationship with symptomatology and sex.
    Zhang ZJ; Peet M; Ramchand CN; Shah S; Reynolds GP
    J Psychiatr Res; 2001; 35(1):23-8. PubMed ID: 11287053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M; Kahn RS; Knott P; Kaminsky R; Cooper M; DuMont K; Apter S; Davis KL
    Arch Gen Psychiatry; 1991 Oct; 48(10):910-3. PubMed ID: 1929760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Lesser JC; Powchik P; Freed LB; Davis BM; Mykytyn VV; Davis KL
    Neuropsychopharmacology; 1987 Dec; 1(1):17-23. PubMed ID: 3509064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homovanillic acid in the prodromal phase of schizophrenia.
    Sumiyoshi T; Kurachi M; Kurokawa K; Yotsutsuji T; Uehara T; Itoh H; Saitoh O
    Biol Psychiatry; 2000 Mar; 47(5):428-33. PubMed ID: 10704954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 3-methoxy-4-hydroxyphenylglycol and homovanillic acid measurements in deficit and nondeficit forms of schizophrenia.
    Thibaut F; Ribeyre JM; Dourmap N; Ménard JF; Dollfus S; Petit M
    Biol Psychiatry; 1998 Jan; 43(1):24-30. PubMed ID: 9442341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.